Form 8-K - Current report:
SEC Accession No. 0001493152-24-048190
Filing Date
2024-11-29
Accepted
2024-11-29 17:00:09
Documents
13
Period of Report
2024-11-26
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40837
  Complete submission text file 0001493152-24-048190.txt   215571

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ogen-20241126.xsd EX-101.SCH 3018
3 XBRL LABEL FILE ogen-20241126_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ogen-20241126_pre.xml EX-101.PRE 24167
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241516814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)